Investors & Media International Stem Cell Corp Announces Second Quarter 2012 Financial Results International Stem Cell Corporation to Host Second Quarter 2012 Financial Results Conference Call at 11:00 am ET on Friday, August 10, 2012 Important message concerning ISCO's ticker symbol and price quotes International Stem Cell Corporation's Co-Chairman and CEO Andrey Semechkin PhD Publishes Letter to Shareholders International Stem Cell Corporation Reports Reaching Milestone in Its Cornea Program International Stem Cell Corporation Scientists Create New Protein-Based Stem Cell Technology International Stem Cell Corporation Announces Marketing Plans for Its Wholly Owned Subsidiary Lifeline Skin Care International Stem Cell Corp Announces First Quarter 2012 Financial Results and Business Highlights International Stem Cell Corporation Scientists to Present Pre-Clinical Research Results at American Society of Gene and Cell Therapy 15th Annual Meeting International Stem Cell Corporation Announces New Stem Cell Manufacturing Technologies to Support its Therapeutic Programs 14 15 16 17 18 19 20 21 22 23 24 << < > >>
